2026-06-30 · adolescent obesity, teen weight, pediatric obesity, AAP guideline, STEP TEENS, family-based therapy · 13 min read

Is Wegovy safe for my 13-year-old?

Wegovy (semaglutide 2.4 mg) is FDA-approved for adolescents 12 and older with obesity, and the STEP TEENS trial (Weghuber 2022, New England Journal of Medicine) showed about 16.1 percent average weight loss at 68 weeks versus 0.6 percent on placebo, with roughly 73 percent of treated adolescents achieving at least 5 percent loss. Gastrointestinal side effects — nausea, vomiting, diarrhea — were the most common reason for stopping, and dose titration in adolescents follows the same stepwise schedule used in adults. The 2023 AAP guideline (Hampl 2023, Pediatrics) endorses pharmacotherapy at age 12 and older for Class I obesity or higher, provided care is paired with intensive health-behavior and lifestyle treatment and there is no active eating disorder. The decision belongs with an adolescent-experienced clinician — a pediatric endocrinologist or weight-management specialist — not with a telehealth checklist.

What does the 2023 AAP guideline actually say?

The American Academy of Pediatrics 2023 Clinical Practice Guideline (Hampl 2023, Pediatrics) is the first major US pediatric obesity guideline since 2007, and it formalizes a stepped intensification model: intensive health-behavior and lifestyle treatment (IHBLT) of at least 26 contact hours over 3 to 12 months is the foundation for any child with overweight or obesity, pharmacotherapy is appropriate at age 12 and older for Class I obesity or higher, and bariatric surgery referral is appropriate at age 13 and older for severe (Class III) obesity. The guideline explicitly rejects watchful waiting, which had been the default in earlier eras. It also asks clinicians to screen for eating disorders, food insecurity, and social drivers of health before intensifying treatment.

Should my teenager be losing weight at all?

Often the answer is weight maintenance, not loss. Because adolescents are still growing in height, holding weight steady while linear growth continues lowers BMI percentile without any intentional loss — and that is the right target for most younger teens below Class III obesity. Active loss is more appropriate in older adolescents with Class II or III obesity, or with weight-driven conditions like type 2 diabetes, severe sleep apnea, fatty liver, or non-mechanical joint pain. The right plan is set by an adolescent-experienced clinician with a current growth chart, not by adult BMI categories or by social-media advice.

What is family-based behavioral therapy?

Family-based behavioral treatment is the highest-evidence non-pharmacologic intervention for adolescent weight management. It treats the household — not just the teen — as the unit of change: parents and caregivers learn behavior-change skills (stimulus control, contingency management, problem-solving), the home food and activity environment is restructured, and the adolescent is partnered with rather than policed. Epstein 2007 (Health Psychology) and Wilfley 2010 (Pediatrics) showed roughly 5 to 10 percent BMI reduction with durable outcomes when delivered at the AAP-recommended 26-plus contact hours. Short, low-intensity counseling — the kind that fits inside a routine pediatric visit — does not reach that threshold and rarely produces durable change.

Are kids getting bariatric surgery now?

Yes, in carefully selected adolescents 13 and older with severe (Class III) obesity at experienced multidisciplinary centers. The Teen-LABS prospective cohort (Inge 2016, New England Journal of Medicine) showed about 26 to 28 percent sustained weight loss at 3 years with resolution of type 2 diabetes, hypertension, and dyslipidemia in a large majority of cases. The American Society for Metabolic and Bariatric Surgery 2018 pediatric position supports referral when first-line care has failed and the adolescent and family are prepared for lifelong follow-up. Selection is the whole story: a comprehensive evaluation, eating-disorder screening, a structured pre-op program, and a long-term plan for protein, calcium, vitamin D, B12, iron, and bone-density monitoring are non-negotiable.

How do I talk about weight without causing an eating disorder?

Use healthy-eating talk, not weight talk. Loth 2015 (Pediatrics) and Neumark-Sztainer 2007 (Archives of Pediatrics and Adolescent Medicine) both showed that parental weight-focused comments raise the risk of disordered eating and binge eating, while parental focus on healthy eating and family meals does not. Avoid weighing your teen in front of peers or siblings, never frame care around appearance, and do not restrict food in a teen with prior restrictive behaviors or active eating-disorder symptoms. Pair every change with curiosity and shared meals, and let the clinician — not the dinner table — handle weight numbers.

What if my teen is an athlete?

Athletes need a different protocol. Mountjoy 2018 (British Journal of Sports Medicine) is the IOC consensus on Relative Energy Deficiency in Sport (RED-S) and is the operative framework for adolescent athletes. Restriction in a growing adolescent athlete risks delayed puberty, amenorrhea, stress fractures, and long-term reduction in peak bone mass. The right approach is adequate calories and protein for training load, attention to iron and vitamin D, sleep protection, and management of weight only under a sports-medicine clinician who is fluent in RED-S. If your teen is restricting, skipping meals, exercising compulsively, or has lost a menstrual period, treat it as a clinical situation, not a discipline question.

Is my pediatrician supposed to bring this up?

Yes. The 2023 AAP guideline asks pediatricians to assess BMI, blood pressure, and weight-related comorbidities at every well-child visit, to talk frankly with families about overweight and obesity, and to refer to intensive health-behavior and lifestyle treatment when indicated. Watchful waiting is no longer recommended. If your pediatrician has not raised the topic and you have a specific concern — rising BMI percentile, snoring or daytime sleepiness, acanthosis nigricans, family history of type 2 diabetes — it is reasonable to start the conversation yourself.

Teen Weight Management: AAP Guideline, GLP-1s, and What Helps

Quick answer

Roughly one in five US adolescents has obesity (Stierman 2021, NCHS Health E-Stats), and another 6 percent meet criteria for severe obesity (Skinner 2018, Pediatrics). The 2023 American Academy of Pediatrics Clinical Practice Guideline (Hampl 2023, Pediatrics) was the first major US pediatric obesity guideline since 2007 and formalized a stepped model: intensive health-behavior and lifestyle treatment of at least 26 contact hours is the foundation, pharmacotherapy is appropriate at age 12 and older for Class I obesity or higher, and bariatric surgery referral is appropriate at age 13 and older for severe obesity. The STEP TEENS trial of semaglutide (Weghuber 2022, NEJM) showed roughly 16.1 percent mean weight reduction at 68 weeks, the SCALE TEENS trial of liraglutide (Kelly 2020, NEJM) showed roughly 4.5 percent reduction, and the Teen-LABS cohort of adolescent bariatric surgery (Inge 2016, NEJM) showed roughly 26 percent sustained loss at 3 years.

The honest framing for families is different from adult care. Growth is still happening, so weight maintenance often beats weight loss. Family-based behavioral therapy is the cornerstone, not the optional starter. Pharmacotherapy is now AAP-endorsed but only inside a comprehensive program with eating-disorder screening. And every interaction needs to be paced carefully — Loth 2015 (Pediatrics) is explicit that weight talk in families raises eating-disorder risk.

How adolescent weight management is defined

Adolescent body weight is interpreted against CDC growth charts using BMI-for-age and sex, not the adult cut-points. The 2023 AAP guideline keeps that framework and layers a stepped intensification model on top of it. The categories below summarize the working definitions used in Hampl 2023; the BMI-percentile boundaries also use an adult BMI cutoff (whichever is lower) once the adolescent BMI crosses 30.

The clinical implication of the table is that an adolescent’s BMI is interpreted as a moving target across childhood, not a static number. See the BMI calculator for the underlying cut-points, binge eating disorder and weight loss and anorexia recovery and weight restoration for the eating-disorder screening that belongs at every step, and prediabetes and weight loss for the metabolic context that often arrives at the same time.

Why adolescent weight management is different from adult care

Growth is still happening — weight maintenance often outperforms weight loss

Adolescents are still gaining linear height for most of this window. Holding weight steady while growth continues lowers BMI percentile without any active loss, and that is the right primary target for most younger teens below Class III obesity. Hampl 2023 is explicit that “intensification” does not always mean active weight loss; it often means stabilizing weight and intensifying the surrounding health behaviors. See weight loss maintenance for the maintenance-first framing.

Family-based behavioral therapy is the cornerstone, not the optional starter

The strongest non-pharmacologic evidence in adolescent weight management is for family-based behavioral therapy delivered at the AAP-recommended 26-plus contact hours. Epstein 2007 (Health Psychology) was the original parent-targeted RCT, and Wilfley 2010 (Pediatrics) is the meta-analysis showing roughly 5 to 10 percent BMI reduction with durable outcomes when the contact-hour threshold is met. Short, low-intensity counseling in routine pediatric visits does not reach that threshold and rarely produces durable change. See behavioral therapy for weight loss and emotional eating and weight loss for the underlying behavior-change framework.

Pharmacotherapy is now AAP-endorsed at ≥12 years for Class I+ obesity

The 2023 AAP guideline endorses pharmacotherapy starting at age 12 for Class I or higher obesity. Weghuber 2022’s STEP TEENS trial in NEJM showed roughly 16 percent loss at 68 weeks on semaglutide 2.4 mg, Kelly 2020’s SCALE TEENS in NEJM showed roughly 4.5 percent on liraglutide 3.0 mg, and Gulati 2024 (JAMA Pediatrics) is the emerging evidence for tirzepatide in adolescents (verify FDA status with your prescriber). Orlistat is FDA-approved at 12 and older, and phentermine is approved at 16 and older. See GLP-1 weight loss overview, Ozempic vs Wegovy, GLP-1 medications compared, and weight loss drug safety for the drug-by-drug detail.

Eating-disorder risk requires every interaction to screen and pace carefully

Loth 2015 (Pediatrics) and Neumark-Sztainer 2007 (Archives of Pediatrics and Adolescent Medicine) both showed that parental weight talk raises the risk of disordered eating, whereas parental focus on healthy eating does not. The clinical rule is firm: never weigh in front of peers or siblings, never frame care around appearance, and never start pharmacotherapy or a bariatric workup in an adolescent with an active eating disorder. See binge eating disorder and weight loss and anorexia recovery and weight restoration for the eating-disorder screening that belongs at every step.

How much each intervention helps in adolescents

The ranking is durable across trials, but the individual ranges are wide. The single most important practical point from the table is that the gap between “lifestyle counseling at adequate dose” and “lifestyle counseling at inadequate dose” is large — the dose-response is real.

5-step adolescent weight-management protocol

1. Use family-based behavioral treatment with ≥26 contact hours as the foundation — never a stand-alone “eat less” conversation. Wilfley 2010’s meta and the Hampl 2023 AAP guideline both treat the 26-hour threshold as the practical floor for meaningful change. The plan should structure the household — meals, sleep, screens, activity — not corner the adolescent. See behavioral therapy for weight loss and mindful eating and weight loss.
2. Screen for binge-eating, restrictive behaviors, body-image distress, and depression before any intensification. Loth 2015 (Pediatrics) and the APA 2023 eating-disorder guideline both put this step before pharmacotherapy or bariatric workup. Do not start either with an active eating disorder. See binge eating disorder and weight loss, anorexia recovery and weight restoration, and depression and weight loss.
3. Anchor the family routine on a balanced plate, family meals 5+ days per week, ≥1 hour of daily activity, ≥9 hours of sleep, and reasonable screen-time limits. The Hampl 2023 behavior recommendations and the broader family-meals literature support this combined behavioral package. See high-protein breakfast ideas, sleep, stress, and weight management, and walking for weight loss.
4. If BMI remains in Class I+ at age 12 or older, discuss FDA-approved pharmacotherapy with an adolescent-experienced clinician. The options at writing include liraglutide, semaglutide, orlistat, phentermine (≥16 years), and, increasingly, tirzepatide — confirm current FDA labels with the prescriber. The pharmacotherapy conversation belongs in a comprehensive program, not a telehealth checkbox. See GLP-1 weight loss overview, weight loss drug safety, and Ozempic side effects.
5. If BMI is Class III at age 13 or older and first-line care has failed, refer to a comprehensive adolescent bariatric program with multidisciplinary evaluation. The Inge 2016 Teen-LABS cohort and the ASMBS 2018 pediatric position both support referral when the criteria are met and the family is prepared. See bariatric surgery overview, bariatric surgery types compared, and bariatric surgery vs GLP-1 medications.

What treatments actually do

Special situations

Eating disorders, body image, and how to talk about weight with a teen

Loth 2015 (Pediatrics) is the most cited paper on this question: in a longitudinal cohort, parental weight talk — even when well-intentioned — was associated with higher rates of disordered eating, binge eating, and unhealthy weight control behaviors. Neumark-Sztainer 2007 (Archives of Pediatrics and Adolescent Medicine) showed the same pattern. By contrast, parental focus on healthy eating, family meals, and shared activity does not raise risk and is associated with better outcomes.

The practical rules are firm. Do not weigh adolescents in front of peers or siblings. Do not frame care around appearance, comparisons, or specific clothing sizes. Use healthy-eating language (“we are working on family meals and sleep”), not weight language (“you need to lose”). Screen for binge eating, restriction, purging, compulsive exercise, and body-image distress before any intensification. The 2023 AAP guideline puts eating-disorder screening into the routine workflow precisely because the population most likely to develop an ED overlaps with the population being treated for obesity. See binge eating disorder and weight loss, anorexia recovery and weight restoration, and behavioral therapy for weight loss for the eating-disorder-aware behavioral pathway.

Adolescent prediabetes, type 2 diabetes, and PCOS

Magge 2024 (Pediatrics) is the current pediatric type 2 diabetes guideline. Youth-onset type 2 diabetes follows a more aggressive trajectory than adult-onset, with faster beta-cell decline and earlier microvascular complications. Metformin remains a first-line agent, lifestyle intervention is paired with it from the start, and the ADA 2024 Section 14 framework supports earlier consideration of GLP-1 medications in adolescents whose disease is poorly controlled. PCOS in adolescents commonly presents with menstrual irregularity, hirsutism, acne, and acanthosis nigricans, and weight gain frequently amplifies the metabolic phenotype — GLP-1 medications are increasingly used for the dual indication of weight and metabolic control under specialist supervision.

The honest framing for families is that an adolescent with prediabetes, type 2 diabetes, or PCOS is in a different prognostic bucket from an adolescent with isolated weight gain, and the workup belongs with a pediatric endocrinologist or an adolescent-experienced clinician. See prediabetes and weight loss, diabetes and weight loss, PCOS and weight loss, and insulin resistance and weight loss.

Athletes, growth, and Relative Energy Deficiency in Sport (RED-S) in adolescents

Mountjoy 2018 (British Journal of Sports Medicine) is the IOC consensus on Relative Energy Deficiency in Sport — the modern framework that replaced the older “Female Athlete Triad.” It applies to male and female adolescent athletes and to non-athletic adolescents with high training loads. The core idea is simple: when energy intake is too low to cover both training and growth, menstrual function, bone mineralization, and recovery suffer first, and stress fractures, pubertal delay, and long-term reductions in peak bone mass follow.

The clinical rule is that adolescents who are still growing and training hard should not be in a deficit unless a sports-medicine clinician with RED-S fluency is involved. Adequate calories and protein for training load, attention to iron and vitamin D, sleep protection, and consistent menstrual tracking are the foundation. If your adolescent athlete has skipped or lost a menstrual period, is restricting, exercising compulsively, or has a stress fracture, treat it as a clinical situation — not a discipline question. See preserve muscle during weight loss, protein intake for weight loss, and osteoporosis and weight loss.

Red flags — when to see a doctor

• Restrictive eating, binging, purging, or compulsive exercise — eating-disorder screen with an adolescent-experienced clinician; see anorexia recovery and weight restoration. NEDA Helpline 1-800-931-2237; 988 Suicide and Crisis Lifeline for safety concerns.
• Unintentional weight loss in an adolescent who is not dieting — rule out endocrine causes (type 1 diabetes, hyperthyroidism), gastrointestinal disease (celiac, IBD), malignancy, and depression. Schedule a primary-care visit within 1 to 2 weeks.
• Severe daytime sleepiness, snoring, or witnessed apnea — pediatric sleep apnea or obesity hypoventilation workup; see sleep apnea and weight loss.
• Pubertal delay, amenorrhea, or stress fractures — RED-S and pubertal endocrine workup (Mountjoy 2018); refer to adolescent medicine or pediatric endocrinology.
• Depression, self-harm, or suicidal ideation — urgent mental-health referral; 988 Suicide and Crisis Lifeline. Do not start pharmacotherapy or a bariatric workup until mental-health stability is established.
• Acanthosis nigricans, family history of type 2 diabetes, or fasting glucose ≥100 mg/dL — pediatric type 2 diabetes screen per Magge 2024; see prediabetes and weight loss.

Sources